Davis Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.04M Sell
28,815
-1,434
-5% -$334K 2.49% 6
2025
Q4
$6.27M Buy
30,249
+1,961
+7% +$388K 2.19% 8
2025
Q3
$5.26M Buy
28,288
+6,770
+31% +$1.16M 1.8% 12
2025
Q2
$3.35M Buy
21,518
+17,089
+386% +$2.63M 1.2% 14
2025
Q1
$682K Buy
4,429
+326
+8% +$51K 0.3% 62
2024
Q4
$583K Buy
4,103
+985
+32% +$153K 0.25% 68
2024
Q3
$503K Buy
3,118
+72
+2% +$11.5K 0.21% 74
2024
Q2
$456K Buy
3,046
+12
+0.4% +$1.78K 0.19% 80
2024
Q1
$457K Sell
3,034
-44
-1% -$7K 0.2% 77
2023
Q4
$495K Buy
3,078
+1,424
+86% +$218K 0.24% 62
2023
Q3
$259K Hold
1,654
0.14% 87
2023
Q2
$274K Hold
1,654
0.13% 94
2023
Q1
$261K Hold
1,654
0.14% 89
2022
Q4
$269K Buy
+1,654
New +$286K 0.14% 95

Other funds holding JNJ

Davis Investment Partners's JNJ Position: Q1 2026 in Review

Davis Investment Partners reduced its Johnson & Johnson (JNJ) stake by 4.7% in Q1 2026, selling an estimated $334K and leaving 28,815 shares worth $7.04M. The position accounts for 2.49% of the portfolio, ranked #6.

Davis Investment Partners first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Davis Investment Partners held 28,815 shares of Johnson & Johnson worth $7.04M as of Q1 2026.
  • Davis Investment Partners sold 1,434 Johnson & Johnson shares in Q1 2026, an estimated $334K.
  • Johnson & Johnson made up 2.49% of Davis Investment Partners's portfolio in Q1 2026, its #6 holding.
  • Davis Investment Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Davis Investment Partners's 13F filing for Q1 2026, filed 20 Apr 2026.